Breast Cancer - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
Preventing Delayed Nausea in Breast Cancer Patients
(Posted: 10/23/2007) - In this trial, different combinations of drugs will be tested to see which is most effective in preventing delayed nausea in women undergoing chemotherapy for breast cancer.
Education and Exercise to Prevent Lymphedema
(Posted: 07/24/2007) - This study compares a lymphedema-prevention education program to the same education program supplemented with an exercise regimen and counseling in women who have been newly diagnosed with breast cancer and who will undergo axillary node dissection.
Reactivating Tumor Suppressor Genes
(Posted: 04/17/2007) - This is the first clinical trial to test the combination of a drug called 5-fluoro-2'-deoxycytidine (FdCyd) and tetrahydrouridine (THU) in humans. Researchers are interested in establishing the maximum tolerated dose and determining how this regimen affects the activity of certain tumor suppressor genes in patients with advanced solid tumors.
Neoadjuvant Treatment of Breast Cancer Using Aromatase Inhibitors
(Posted: 02/20/2007) - In this trial, women with estrogen receptor-positive breast cancer will be treated with one of three aromatase inhibitors (AI)--exemestane (Aromasin), letrozole (Femara), or anastrozole (Arimidex)--before surgery to determine which AI(s) to use in a future trial that compares neoadjuvant AI therapy and neoadjuvant chemotherapy.
Trial of Four Schedules of Adjuvant Chemotherapy for Breast Cancer
(Posted: 03/30/2004, Updated: 11/22/2006) - This trial compares the effectiveness of four different treatment schedules using the drugs doxorubucin, cyclophosphomide, and paclitaxel in treating patients who have undergone surgery for stage l, ll, or lll breast cancer.
(Posted: 10/23/2007) - In this trial, different combinations of drugs will be tested to see which is most effective in preventing delayed nausea in women undergoing chemotherapy for breast cancer.
Education and Exercise to Prevent Lymphedema
(Posted: 07/24/2007) - This study compares a lymphedema-prevention education program to the same education program supplemented with an exercise regimen and counseling in women who have been newly diagnosed with breast cancer and who will undergo axillary node dissection.
Reactivating Tumor Suppressor Genes
(Posted: 04/17/2007) - This is the first clinical trial to test the combination of a drug called 5-fluoro-2'-deoxycytidine (FdCyd) and tetrahydrouridine (THU) in humans. Researchers are interested in establishing the maximum tolerated dose and determining how this regimen affects the activity of certain tumor suppressor genes in patients with advanced solid tumors.
Neoadjuvant Treatment of Breast Cancer Using Aromatase Inhibitors
(Posted: 02/20/2007) - In this trial, women with estrogen receptor-positive breast cancer will be treated with one of three aromatase inhibitors (AI)--exemestane (Aromasin), letrozole (Femara), or anastrozole (Arimidex)--before surgery to determine which AI(s) to use in a future trial that compares neoadjuvant AI therapy and neoadjuvant chemotherapy.
Trial of Four Schedules of Adjuvant Chemotherapy for Breast Cancer
(Posted: 03/30/2004, Updated: 11/22/2006) - This trial compares the effectiveness of four different treatment schedules using the drugs doxorubucin, cyclophosphomide, and paclitaxel in treating patients who have undergone surgery for stage l, ll, or lll breast cancer.
